Transmedics
TMDX
240 hedge funds and large institutions have $2.73B invested in Transmedics in 2023 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 106 increasing their positions, 62 reducing their positions, and 28 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 62
64% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 28
38% more call options, than puts
Call options by funds: $17.3M | Put options by funds: $12.6M
21% more capital invested
Capital invested by funds: $2.26B → $2.73B (+$467M)
7% more funds holding
Funds holding: 224 → 240 (+16)
7.09% more ownership
Funds ownership: 92.85% → 99.94% (+7.1%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
Top Buyers
Top Sellers
TMDX Hedge Fund Activity: Q2 2023 in Review
240 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q2 2023, worth a combined $2.73B — up 21% from $2.26B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new TMDX positions and 28 closed out — a net gain of 18 holders — while 106 added to existing stakes and 62 trimmed.
The largest buyer was Invesco, adding an estimated $50.4M. The largest seller was Summit Partners Public Asset Management, cutting an estimated $17.9M.
- 240 institutional investors held Transmedics (TMDX) as of Q2 2023, up from 224 in Q1 2023.
- Funds reported $2.73B of Transmedics stock for Q2 2023, up 21% quarter-over-quarter.
- 46 funds opened new Transmedics positions in Q2 2023 and 28 closed out, a net change of +18 holders.
- The largest Transmedics buyer in Q2 2023 was Invesco, an estimated $50.4M added.
- The largest Transmedics seller in Q2 2023 was Summit Partners Public Asset Management, an estimated $17.9M sold.
Based on aggregated 13F filings for Q2 2023.